Works matching AU Pomykala, Kelsey L.
Results: 24
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 342, doi. 10.1007/s00259-024-06891-8
- By:
- Publication type:
- Article
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2196, doi. 10.1007/s00259-023-06163-x
- By:
- Publication type:
- Article
Oncologic Staging with <sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1906, doi. 10.2967/jnumed.123.265751
- By:
- Publication type:
- Article
Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1102, doi. 10.2967/jnumed.122.264996
- By:
- Publication type:
- Article
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 685, doi. 10.2967/jnumed.122.265353
- By:
- Publication type:
- Article
Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 347, doi. 10.2967/jnumed.122.264900
- By:
- Publication type:
- Article
Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264394
- By:
- Publication type:
- Article
Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264394
- By:
- Publication type:
- Article
Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.122.264394
- By:
- Publication type:
- Article
Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Prostate Cancer: We have the answers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.264394
- By:
- Publication type:
- Article
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.245803
- By:
- Publication type:
- Article
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.245803
- By:
- Publication type:
- Article
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.245803
- By:
- Publication type:
- Article
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.245803
- By:
- Publication type:
- Article
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.245803
- By:
- Publication type:
- Article
Total-body 68Ga-PSMA-11 PET/CT for bone metastasis detection in prostate cancer patients: Potential Impact on bone scan guidelines.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.230318
- By:
- Publication type:
- Article
Perceived Misinterpretation Rates in Oncologic <sup>18</sup>F-FDG PET/CT Studies: A Survey of Referring Physicians.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 12, p. 1925, doi. 10.2967/jnumed.114.145607
- By:
- Publication type:
- Article
The future of radiosynoviorthesis: bright or bleak?
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 66, n. 4, p. 345, doi. 10.23736/S1824-4785.22.03475-6
- By:
- Publication type:
- Article
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times.
- Published in:
- European Radiology, 2023, v. 33, n. 9, p. 6179, doi. 10.1007/s00330-023-09580-6
- By:
- Publication type:
- Article
Simultaneous multislice diffusion-weighted imaging versus standard diffusion-weighted imaging in whole-body PET/MRI.
- Published in:
- European Radiology, 2023, v. 33, n. 4, p. 2536, doi. 10.1007/s00330-022-09275-4
- By:
- Publication type:
- Article
(18) F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1227, doi. 10.1002/cncr.27866
- By:
- Publication type:
- Article
"A net for everyone": fully personalized and unsupervised neural networks trained with longitudinal data from a single patient.
- Published in:
- BMC Medical Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12880-023-01128-w
- By:
- Publication type:
- Article
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 4, p. 603, doi. 10.1093/neuonc/not166
- By:
- Publication type:
- Article